Related by context. All words. (Click for frequent words.) 72 § #.#-# [004] 72 #.#-# b [001] 71 Income Tax Regs 70 #.#-# b [002] 70 #.# subd [004] 69 #.#-# Equal Opportunity 69 § #.#-# [007] 68 USC § #u 68 TCA § #-#-# [003] 67 Colo. Sess 67 § #-#-# b [003] 67 NJAC #:#-#.# 67 #.# 5T 66 USC § #a [001] 66 CFR § #.# [006] 66 #.# subd [006] 66 CFR § #.# [004] 66 USC § #c 66 See USSG § #B#.# 65 WpHG mit dem Ziel 65 Legal #.# 65 Repl. 65 § #.# [002] 65 § #-#-# [005] 65 NYCRR #.# [003] 65 § #a [002] 64 #.#A [005] 64 See USSG § #A#.# 64 § #A.# 64 FAR #.#-# [001] 64 § #-#-# [004] 64 See id 64 CFR #.#b 64 § #.# [004] 64 Pa.RAP 64 #.#-# [005] 64 Vernon Supp 64 CFR § #.# [008] 63 § #-#.# [003] 63 vphl Norwegian Securities 63 CFR § #.# [002] 63 NJSA 2C :2 63 #.# subd [003] 63 b Vernon Supp 63 #.# subds [001] 63 CFR #.# c 63 § #-#-# [002] 63 CFR § #.# [007] 63 See ARS § 63 § #c 63 #-#.# [016] 62 NJSA #:#-# [004] 62 P. #a 62 See USSG § #D#.# 62 § #.# [006] 62 Id. § 62 #.#-# [001] 62 END FOOTNOTE FOOTNOTE 62 § #.# [003] 62 Fed.R.Civ.P. 62 § #E 62 Reproduced Record RR 61 NJSA 2A #A 61 See USSG 61 IRCP 61 i #.# subds 61 § #-#.# [004] 61 § § #-#-# [001] 61 CFR § #.# [003] 61 § #-#.# [001] 61 § #-# [004] 61 § #a [003] 61 RC #.# B [001] 61 See TCA § 61 USC § #a [002] 61 CFR #.# [002] 61 HRS § #-# [001] 61 USC § #t 61 § #-#-# b [001] 61 Exercising jurisdiction 61 USC § #a b 61 CFR #.# [008] 61 USC § #f 61 NTQ 61 § 7B 61 #.# subdivision [004] 61 CFR #.# b 60 Appendix 3B Page 60 USC #a [001] 60 CFR § #.#b 60 #-#.# [017] 60 Prof. Code § 60 CFR § #.# [001] 60 IRC § § 60 M anagement 60 #.#-# [020] 60 LSA RS #:# [001] 60 Slip Op 60 La.Code Crim.P. art 60 wv ` 60 LSA RS #:# [002] 60 § #.#-# [001] 60 Supp. 60 section #AA 60 Rev. Proc 60 § #:# [001] 60 USC #d 60 USC § #a c 59 OCGA § #-#-#.# 59 IRC § 59 Subparagraph 59 § #.# Vernon 59 #a #a [003] 59 #.#-# [016] 59 USC § #b [001] 59 Def. s 59 NJSA 2C :5 59 USC § #b [002] 59 NCGS § #A 59 rev. 59 CFR #.# [006] 59 See Restatement Second 59 USC § #e 59 HMQ MT 59 CFR § #.# [005] 59 § #-#-# c [001] 59 ARS § 59 AOQ MT 59 § #.#.# [002] 59 USCA § 59 SEC Rule #b 59 NYCRR #.# [001] 59 Ord. 59 WpHG folgendes mitgeteilt 59 See OCGA § 59 App.R. 58 Section #.# [001] 58 USC § #A 58 La. RS #:# [001] 58 Opp'n 58 FOF ¶ 58 #.# subds [002] 58 Arch Dermatol 58 NJSA #:# [001] 58 ` @ gn 58 :9 58 NJSA #:#-#.# [001] 58 OCGA § #-#-# [002] 58 Veröffentlichung einer Mitteilung nach 58 Ark. Sup 58 Judgments § 58 = null 58 USC § #a [003] 58 Pa.CS § 58 Stats. 58 # endif 58 USSG § 58 NJSA 2A :# 58 #U [005] 58 NJSA #:#-# [001] 58 mhw ` 58 Bankruptcy Code § 58 Va. Code § 58 MSc Qualified Person 58 USC § #o 58 Fam. Code § 58 Subsection b 58 NCGS § 58 § #.#.# [001] 58 Compl. 58 ProLogis Declares Dividends 58 HRS § #-# [002] 58 OCGA § #-#-# [004] 58 Pa.CSA § 58 subsection c 58 See INA § 58 Tenn. R. Civ 57 FAR #.#-# [003] 57 NASD Marketplace Rule 57 DFARS 57 Sentencing Guidelines Manual 57 cmt 57 CFR § § #.# [001] 57 % #gt 57 Eur J Cancer 57 NJSA #:#-# [002] 57 NOTIFICATION OF MAJOR INTERESTS 57 § #-#-#.# 57 USSG § #B#.# [002] 57 hoc disclosure 57 #A.# [005] 57 #-#.# BID 57 @ y qW 57 NJSA #:#-#.# [003] 57 SDNY Mar. 57 § #A [003] 57 Id. ¶ 57 Ann Intern Med 57 Compl 57 TCA § 57 e xcept 57 Obes Res 57 CFR pt 57 0 document.write sline 57 var = # [001] 57 Resp 57 § #-#-# [007] 57 § #-# [001] 57 Ohio Adm.Code #-#-# 57 Disclosure Requirement 57 #.#-# Instructions 57 #.#/#.# ICICI 57 Docket Entry No. 57 § 7A 57 Stimmrechtsmitteilung pursuant 57 LBR #-# 57 #a #a [002] 57 OCGA § #-#-# [003] 57 La. Code Civ 57 § #-#-# c [002] 57 Civ. Code § 57 weighted avg 57 DAILY FORECAST FOR 57 Eur Respir J. 57 § #C#.# 57 Dkt 57 USC #a [002] 57 #B#.# 57 @ gn 57 § #A [001] 57 La. RS #:# [003] 57 ps :# 57 competitively procured pursuant 57 USCS § 57 CFR #.# [007] 56 Gov't Code § 56 USC § #d 56 SEK -#.# -#.# [002] 56 wef 1st 56 WORLD ENTERTAINMENT NEWS NETWORK 56 Compl. ¶ 56 len = 56 0 & 56 FINRA Rule 56 Certifications Commercial Items 56 #d# [001] 56 LOUIS Oshiomogho Atogwe 56 unsigned char 56 § #b [001] 56 § #-#-# [001] 56 Pa. Code § 56 § #-# [003] 56 Offerors Commercial Items 56 #a subdivision 56 NASD Rule 56 § #B 56 Dkt. No. 56 w illus 56 η 56 J Affect Disord 56 OCGA § #-#-# [005] 56 = sizeof 56 Rule #:#-# [001] 56 Rev. Rul 56 CODE § 56 WL # SDNY [001] 56 CFR #.# d 56 Counterparty Criteria 56 subds 56 DTR #.#.# b 56 #.#-# Offeror Representations 56 § #-#-# [006] 56 nepalnews.com mk 56 ID nBMA# 56 SEC Rule #g# 56 Eur Urol 56 R. #:#-# 56 #.# subdivision [002] 56 MR Civ 56 IC § #-# 56 jrw ccg 56 Rheumatol 56 Ann Rheum Dis 56 subparagraph B 56 Ark. R. Civ 56 Ohio Adm.Code 56 Eur Heart 56 SEBI ICDR Regulations 56 App'x 56 Rule #:#-# b 56 First BanCorp Announces 56 Rosenkrantz supra 56 SCR #:#.# [001] 56 CrR #.# 56 OCGA § #-#-# [006] 56 WISCONSIN STAT 56 :5 56 Multilateral Instrument 56 Section #-#-# [007] 56 § #-#-# [003] 56 suppl 56 Section #AA [002] 56 #g# 2 56 Placement QIP 56 #/Aug 56 Evid. Code § § 56 MHPAEA 56 § #A [002] 56 Agreement constitutes discloseable 56 height #px [002] 55 ORS #A.# 55 NRS #.# [003] 55 Resp't 55 h g 55 FAR #.#-# Contract 55 último movimiento 55 hereof shall 55 dpa nr 55 NJSA #:# [002] 55 Cropredy Res 55 reached vi vii 55 Severability 55 sizeof struct 55 § #e 55 EMRG VIO 55 % #lt ;/ 55 κ 55 OCGA § #-#-# [007] 55 y r 55 #S #S [002] 55 Code § #.#-# [001] 55 vQsQn 55 SURETY LICENSES c 55 POL PRO 55 construing statute 55 + sizeof 55 Osteoporos Int 55 Okla. Stat 55 pp. #-# fn 55 Liquidity Ratio 55 substitute LOCs 55 subsections b 55 § § #.# [002] 55 NJSA #A 55 SCR #:#.# [002] 55 DC Code § 55 J Pediatr 55 Exs 55 wQ @ b 55 DISCUSSION AND POSSIBLE APPROVAL 55 USC § #k 55 manmohan@sansad.nic.in soniagandhi@sansad.nic.in oAprimo Marketing TM 55 § #-#.# [002] 55 dpa tg 55 Exh 55 J Am Soc 55 Code § #-#.# 55 Pesos Ps 55 Certifications Commercial 55 h r 55 Rule #:#-# [002] 55 RCW #.#A.# 55 MC# [001] 55 DGAP PVR Publication 55 = argv 55 Evid 55 hemoglobin Hb 55 ERISA § 55 Pharmacother 55 IIROC Dealer Member 55 LONG BEACH Sportfishing Berth 55 CICA Accounting Guideline 55 #-#-#.# [004] 55 Private Issuer #g# 55 Kidney Int 55 # wQ 55 CFR #.# [005] 55 Neurol 55 = strlen 55 LEGAL PROCEEDINGS 55 Charlie Manuel flips 55 Washingtonville Wash 55 AUTOMATIC WITH OVERDRIVE 55 La.RS #:# [003] 55 #.# SPOT GOLD 55 Joel Roelants BEL KTM 55 scienter requirement 55 Pl. s 55 § #a [001] 55 Filing Requirements 55 Code § #-# [001] 55 Code Civ 55 #:#-# [002] 55 s#A [002] 55 LSA CCP art 55 function var = 55 dpa sch 55 y u 55 Subsection c 55 § #B#.# [002] 55 GLc 55 dpa db 55 #B.# [002] 55 subsection d 55 #.# wud 55 SUMMARY JUDGMENT 55 DISMISSED WITH PREJUDICE 55 DFAR #.#-# 54 J Clin Oncol 54 FAR #.# 54 subsec 54 @ vw 54 CFR § § 54 CEQA Guidelines 54 Maj. Op 54 Joshua Coppins NZL Yamaha 54 DJ DGAP PVR Publication 54 Amending Directive 54 Internal Revenue Code § 54 RC #.# B [002] 54 CFR § § #.# [002] 54 Defs. 54 #.# subd [002] 54 Segregated Facilities Feb 54 NJSA #:#-# [003] 54 EFFECTIVE DATE 54 nil p SHP 54 M Models Excluded 54 dpa wh 54 w # yQ 54 Section #.#.# [001] 54 Schizophr Res 54 res wud 54 Ann Oncol 54 ISIN Number 54 Dividend Date 54 People v. Waidla 54 p SHP Rs 54 Scheme Effective Date 54 NJSA #:# C 54 Dkt. 54 Pub. L. #-# [001] 54 Lnk 54 sup wud 54 Ranges AUD USD 54 Assigns Outlooks 54 ARS § #-# [001] 54 scs 54 Declares Dividend Quick Facts 54 HRS § 54 CPLR § 54 #CCF 54 Pl. 54 xed 54 vide Notification No. 54 AASB #-# Amendments 54 Nationality Act INA 54 +6 bps 54 dpa si 54 USC § § #e 54 Offerors Commercial 54 Minn. R. Crim 54 Cal. Rules 54 str = i 54 #.# Kenyan Shilling 54 -#.# = RR 54 PS § 54 mso ansi language 54 Variable Interest Entities FIN 54 XIV § 54 Ranges Cable 54 KRS #.#-# 54 SEBI Guidelines 54 J Clin Psychiatry 54 Suppl. 54 NJSA #A #A 54 Cth Corporations Act 54 DFAR 54 § #b [003] 54 Code § #A [002] 54 Proposed Arrangement 54 MCL #.# [002] 54 THE TECHNICAL INDICATOR 54 END FOOTNOTE * 54 Nephrol 54 está en después del 54 n h r 54 By 3lilangels Read 54 asterisk denotes 54 FAR #.#-# Equal Opportunity 54 dpa dg 54 dpa sib 54 #J# [004] 54 CAMELS rating 54 Income Tax Assessment 54 supportLists 54 mere scintilla 54 FFDCA 54 Brigid Gaffikin bg bg 54 #.#-# Convict Labor 54 dpa rt 54 Assigns LS 54 Dry Powder Inhalers 54 FAR #.#-# Prohibition 54 Assurance Pensions 54 Cochrane Database Syst Rev. 54 Bilgena Read Terms 54 ^ sup -1 54 Immtech scientists 53 arket 53 KSA #-# [001] 53 abstr 53 § § #-# [001] 53 quoting Restatement Second 53 Consensus +#.# 53 # et seq 53 RC #.# F 53 ÿÿ 53 Trust Ser 53 Crit Care 53 #.# subdivision [003] 53 NIH Publication 53 Psychopharmacol Bull 53 HZW 53 #:#-# [020] 53 RC #.# [002] 53 Continuous Disclosure 53 § #.# subd [005] 53 § #.# [001] 53 #CCD 53 Aplt 53 suppl. 53 MOODY 'S INVESTORS SERVICE 53 ABN AMRO MINIs 53 r n 53 Weighted Average Price 53 NJSA #A :# 53 § #-#-# [008] 53 # -# [002] 53 Mol Psychiatry 53 ` vQsQn 53 Pr TSX 53 Al Bawaba www.albawaba.com 53 Depositories Act 53 Ranges EUR USD 53 Subsections 53 ¿ HAY UN 53 qW 53 R. CIV 53 § § #-#-# [002] 53 Eur Respir J 53 NDCC § 53 love veronica Mars 53 vn @ 53 doc. 53 Recent Accounting Pronouncements 53 dpa br 53 fprintf stderr 53 Wyo. Stat 53 Bus. & 53 #.#-# #.#-# #.#-# #.#-# 53 CONST 53 NYCRR #.# [002] 53 La.RS #:# [002] 53 DR #.#.# 53 Ptf 53 #A NCAC 53 Expert Opin 53 ¼ l 53 Stmt 53 Y# [004] 53 Rule #-#.# 53 Material Fact 53 #S #S [001] 53 de acuerdo con 53 #.#/# EUR CHF 53 patrick.graham @ thomson.com 53 évaluation 53 Nephrol Dial Transplant 53 DFARS #.#-# 53 CP#/# 53 Stochastic indicate bearish 53 consiste 53 #.#/# [012] 53 subsection h 53 Immtech clinical trials 53 FASEB J. 53 GBP JPY EUR JPY 53 mso fareast language 53 subparagraph b 53 Loss Severity Rating 53 n # # 53 = #.#f 53 ii iii 53 twds 53 i g 53 SECURITIES ACT RSO 53 CFR § 53 MRS § 53 M spud #-#-# 53 FAR #.#-# Offeror Representations 53 Gold . GOL 53 Docket Entry 53 Section #-#-# [005] 53 PFICs 53 Hr'g Tr 53 ALASKA COMMUNICATIONS SYSTEMS GROUP 53 Instalment Warrants 53 Circular dated 53 Dent Res 53 -mother Arndrea 53 INTRODUCTION I. 53 ID nBMB# 53 nancial 53 La. RS #:#.# 53 Breakevens 53 NZPA WGT 53 CUSIP ISIN 53 vide notification 53 Rui Goncalves POR KTM 53 #.# subd [005] 53 R.# [001] 53 RCW #A.#.# [002] 53 NJSA 2C :# 3a 53 #.#.#R 53 DOSAGE AND ADMINISTRATION 53 Elias Zacarias 53 AUTOMATIC SEQUENTIAL PORT 53 Maintenance Requirements 53 #.#.#.#.#.# 53 s.# [002] 53 La. RS #:# [002] 53 tendering holders 53 certif 53 #o [002] 53 No. #CA# [002] 53 vi vii 53 Forex Flows 53 YEAR YEAR 53 xsl template 53 = NULL [002] 53 constitutes discloseable transaction 53 u h 53 Minn. R. Civ 53 jrw 53 § #A b 53 Solvency II Directive 53 l html 53 RESTATEMENT SECOND OF 53 MLN EUROS 53 Sebastien Pourcel FRA Kawasaki 53 Shadowman logo 53 Australia # ALEATORY 53 DEER Antlered 53 Reply Br 53 Maximilian Nagl GER KTM 53 Amount Amount 53 section #-#-# [001] 53 OS# § 53 § #D#.# 53 Tumor Response 53 APTIMA HPV assay 53 Second Supplemental Indenture 53 Clin Psychol Rev 53 ρ 53 CPI MoM YoY 53 dpa jb 53 u cn 53 FOR AN OPEN 53 -#.# USD JPY [002] 53 Civil Procedure Rule 53 Gold equivalent AuEq 53 Vestibulum 53 PURSUANT TO 53 #,# manats 53 Ferlay J et al 53 Randomized Controlled Trials 53 -1 -2 53 ord = + krdDartOrd 53 - Non GAAP [031] 53 Arch Pediatr Adolesc Med 53 Scrip Dividend Scheme 53 Transcript Docket 53 Xavier Boog FRA Kawasaki 53 #CCC 53 Section #AA [001] 53 Swap Transactions 53 #-# vphl Norwegian 53 unsigned int 53 VESTED 52 NAQ 52 section #WB 52 KRS #.# [003] 52 echocardiographic parameters 52 EMEA Subsidiaries 52 cytochrome c oxidase 52 Arch Neurol 52 THE COSMOS ROCKS 52 J Virol 52 = NULL [001] 52 Steven Frossard FRA Kawasaki 52 HOLLINGER E grounded 52 Mutual Funds Regulations 52 UNI XC 52 #-#.# [026] 52 END FOOTNOTE 52 Defined Terms 52 ` rk 52 Am Fam Physician 52 TAG Tegernsee Immobilien u 52 Original Bidder Statement 52 NYSE Arca Equities 52 Eur J Pharmacol 52 SEBI SAST Regulations 52 Kim Clijsters Bel 52 dpa jbp 52 pawel.sobczak @ thomson.com 52 Emini S 52 2 hd #-#/# 52 Cholinesterase Inhibitors 52 #.#A [001] 52 #.# Crores [003] 52 ESMO Accepted Abstract 52 SR ISE 52 FAR Clause #.#-# 52 nondischargeability 52 dpa fm 52 CNA jy 52 #-#.# [014] 52 CICA Handbook 52 J Child Adolesc 52 twd ccg 52 CONVERSION OF 52 requir 52 e h r 52 # subd 52 UK Today Editoweb 52 Appendix 3B Exercise 52 xiv inclusive 52 #:#-# Abstract Free [001] 52 AML CTF Act 52 MIASJ#PUS #.# 52 Complaint ¶ 52 dkt 52 Armendariz supra 52 De Varon 52 TCA #-#-# [003] 52 χ 52 Code § #-# [002] 52 thereof Controls 52 Rule XIX 52 DTR #.#.# 52 Article XIII 52 FAR #.#-# Instructions 52 Ala. R. Civ 52 Veröffentlichung gemäß § 52 Notification Related 52 #b# [004] 52 t h r 52 Ordinance Cap. 52 GL c 52 TVID 52 Notice #-# [001] 52 1L #-#/#L 52 BRITISH POUND SWISS FRANC 52 deoxy 52 spud #-#-# drlg [002] 52 Y Y -#.# 52 r w 52 MAINTAINS HOLD 52 Thromb Haemost 52 KSA #-# b 52 nullhe 52 Mexican Peso Futures 52 subsection f 52 Code § #-# [003] 52 s.# [001] 52 dpa cb 52 lorem 52 p.# [001] 52 § #L#.# b 52 NDCC ch 52 ADDITIONAL INFORMATION .vectorless 52 Int Clin Psychopharmacol 52 Ref. 52 ProShares UltraShort ETFs 52 Am J Epidemiol 52 ASTC Settlement Rules 52 PARAGRAPH 52 dpa kr 52 Slip op 52 Rzeczpospolita pp. A1 52 W#RGZ 52 #-#-# COPYRIGHT 52 § #E#.# 52 krn 52 Year Treas Bond 52 RELEASE ACCORDING TO 52 Doc. No. 52 VSA § 52 MGL c 52 #/#/à = 52 Appendix 4E 52 DR #-# 52 Somerville Hse 52 Supplementary Information 52 pY @ q 52 Revised Loan Amount 52 DARWINS 52 Proposed Rule 52 Underlying Parcels 52 #/#L #-#/#L 52 certi 52 photo Letisha Henderson 52 STATE EX REL 52 idx 52 FERC Stats 52 Obstet Gynecol 52 S1 S# [002] 52 PAJA 52 NAIC RBC 52 #.# -#.# [005] 52 Code § #.# [004] 52 Claudio Abbado conductor 52 Suppl 52 gold futures GCZ0 52 Psychosom Med 52 meaning ascribed thereto 52 KSA #-# d 52 LEXIS # [001] 52 ccc + 52 Am J Cardiol 52 § § #-# [003] 52 IDR F1 52 Am Med Assoc 52 INVESTMENT PLAN 52 Indirect Costs 52 C.3 52 AktG 52 § § #-# [002] 52 Rule #h 52 Minn. R. Evid 52 dpa sm 52 garantie 52 Maggie Gill Austern 52 Arch Intern Med 52 DR #.#.#R 1 52 ARS § #-# [002] 52 Doc. # 52 Motor Vehicle Ordinance 52 Hall BF Poster 52 Accounting Standard AASB 52 TAB Treble 52 riesgo 52 NOT FDIC NCUA 52 #-#.#.# [001] 52 § #.# b 52 PTI LKJ 52 rated Pfd 52 § #:# [002] 52 Remuneration Code 52 ICRA assigns ` 52 lv dismissed 52 p laintiff 52 Position EITF #-#-# 52 batas na 52 Pen. Code § #.# [001] 52 argc 52 #A.# [001] 52 Br J Clin Pharmacol 52 en vertu de la 52 Grandfathered Plans 52 B.2 52 J Clin Endocrinol Metab 52 PTI RHL 52 Pricing Supplement 52 WENN FIRST 52 SEK -# 52 CICA Section 52 Rs.# w 52 RSMo 52 Revised Guidelines 52 -India Kanishka bombing 52 ANNEXURE B 52 ALS Analytical 52 Psychiatry Res 52 Takeover Regulations 52 Medicure Announces 52 Neschen AG 52 dpa hl 52 Advisers Act 52 Miscellaneous Fares 52 mso footer margin 52 Deriv 52 ÿÿ ÿþÿÀ ÿ ® 52 dpa ms 52 Tariff Order 52 #A #A [002] 52 EURNZD 52 Davide Guarneri ITA Yamaha 52 #.#B [003] 52 Arch Dis Child 52 La.Civ.Code art 52 Mol Med 52 SEK -#.# [003] 52 ND Tex. 52 Miss. Ct 52 #.#/#.#/#.# [002] 52 minor op.# 52 #/#/EEC [002] 52 Ann Neurol 52 Nancy Liu ENDITEM 52 Topics Covered I. INTRODUCTION 52 :7 52 Offerors Commercial applies 51 l u 51 Etf Un TSX 51 neuropathy sensory 51 #-#.# [011] 51 hd #-#/#L 51 printf n 51 consequential amendments 51 INCLUDING CONTACT DETAILS 51 Reply Brief 51 dated #.#.# [002] 51 Dec# 0 51 overcollateralization OC tests 51 #j [001] 51 CFTC Commitments CME 51 d h 51 Nasdaq Listing Rule 51 No. #CA# M 51 Proposing Release 51 ° ú 51 Toxicol 51 Sensex dips 51 Gen Intern Med 51 Supplementary Table 51 Rupee plunges 51 RU EUROPE EEU EMRG 51 #B.# [001] 51 jkun 51 Takeovers Regulations 51 #.#-# Affirmative Action 51 ERRED BY 51 de minimis exception 51 Contributed Surplus 51 Eur J Neurol 51 OCGA § 51 USC § #j b 51 HI PAYS 51 Undisputed Facts 51 Diabet Med 51 4px 51 #:#-# Abstract Free [003] 51 null nullnull 51 #-#/#L #-#/#L 51 wef #.#.# [002] 51 O. Reg 51 Enforceability 51 Arch Facial Plast 51 Swap Dealer 51 facilisis 51 Kotak Sec 51 IRFs 51 Sentencing Guidelines Manual USSG 51 #-# LISTING OF 51 #-#/#L #/#L 51 § #-#-# b [002] 51 INA § 51 Noncritical violations found 51 ADJUDGED 51 ORS #B.# 51 GEM Listing Rules 51 withholdable payments 51 CNA vm 51 Customs Tariff Act 51 constitute discloseable transaction 51 Inflammatory Pain 51 íà 51 Shelf Registration 51 Miraculins Announces 51 Health Syst Pharm 51 Hedging Relationships 51 USSG § #K#.# b 51 invt 51 Siemens Aktiengesellschaft 51 Acquisi 51 Rule 2a 7 51 Free Full Text 51 WpUG 51 Cremer BMF & 51 NJAC 6A 51 reh'g denied 51 2d Dept 51 Michelle Rama mr 51 #:#-# Abstract Free [007] 51 REP FREQ #.# 51 s Opp'n